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Mycobacterium tuberculosis CarD, 
an essential global transcriptional 
regulator forms amyloid-like fibrils
Gundeep Kaur1,2, Soni Kaundal1, Srajan Kapoor1, Jonathan M. Grimes2,3, Juha T. Huiskonen  2,4 
& Krishan Gopal Thakur1
CarD is an essential global transcription regulator from Mycobacterium tuberculosis (Mtb) that binds 
RNA polymerase and activates transcription by stabilizing the transcription initiation complex. 
Available crystal structures have captured two distinct, monomeric and domain-swapped homodimeric, 
oligomeric states of CarD. However, the actual oligomeric state of CarD in solution and its biological 
relevance has remained unclear. Here, we confirm the presence of the homodimeric state of CarD in 
solution by using synchrotron-based small-angle X-ray scattering. Furthermore, by using biochemical 
and biophysical experiments, in addition to mass-spectrometry, transmission electron microscopy, 
and confocal imaging, we show that CarD is the first soluble cytosolic protein in Mtb which displays the 
tendency to form amyloid-like fibrils both in vitro as well as in vivo. We demonstrate that the deletion 
of the fourteen N-terminal residues involved in domain-swapping hampers amyloid formation, thus, 
suggesting that domain-swapping is crucial in amyloidogenesis. The discovery of the amyloidogenic 
property of an essential cytosolic global transcription regulator, CarD, in a pathogenic bacteria will 
further open up new frontiers in research.
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), was ranked among the top 10 causes of death 
worldwide for claiming 1.4 million lives worldwide in 20161. A remarkable feature that makes Mtb one of the 
most successful pathogens is its ability to remain in a dormant/latent state for decades in the host before the 
onset of the disease as well as after the infection2. The formation of persister/dormant bacilli mainly involves 
fine tuning of transcriptional profile which involves coordination and interaction between the RNA Polymerase 
(RNAP) and the other transcription regulators and/or messenger molecules3. RNAP is an essential and key 
enzyme involved in transcription4,5. With the evolution in the biological complexity, RNAP have also evolved 
from the simplest single polypeptide chain in viruses to multi-subunit enzyme in bacteria, archaea and eukary-
otes (Reviewed in6). Bacterial RNAP, a validated drug target7, is composed of five subunits (α2ββ’ω) which assem-
ble to form a core-enzyme4,5. Transcription is a complex multistep process and several proteins like sigma (σ) 
factors, CarD, RbpA, DksA, Transcription-Repair Coupling Factor (TRCF) and many others, reversibly bind 
RNAP (core-enzyme) and aid transcription initiation, elongation or termination steps (Reviewed in8,9).
CarD, an essential global transcription regulator was discovered in 2009 and belongs to CarD_CdnL_TRCF 
family of transcription factors. CarD is a highly expressed protein having about 3000 molecules (~1.7 µM) per cell 
under exponential growth conditions10,11. The levels of CarD are highly up-regulated (~3 to 20-fold) in response 
to starvation, genotoxic, oxidative and antibiotic stress conditions and is required for persistence of Mtb within 
host10. The CarD depletion leads to upregulation of rRNA levels under stress conditions suggesting CarD regu-
lates transcription of the rRNA operon10. However, recent studies demonstrate that CarD activates transcription 
by stabilizing an open promoter complex by preventing collapse of the transcription bubble11–13. Using fluores-
cent reporter based transcription assays Rammohan et al. proposed that CarD stabilizes open promoter complex 
by a two-tiered kinetic mechanism i.e. CarD activates transcription by both increasing the rate of opening and 
decreasing the rate of bubble collapse11. Weiss et al., reported that the interaction of CarD with RNAP β-subunit is 
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responsible for mediating Mtb viability, rifampin resistance, and pathogenesis14. Hence, disrupting CarD/RNAP 
β-subunit interaction has been proposed as an alternate strategy for drug development14. Since Mtb transcription 
machinery is less stable than that of fast growing bacteria such as E. coli12, to partially compensate for low stabil-
ity, CarD and RbpA, two essential transcription factors, act synergistically to activate transcription in Mtb15–17. 
Garner et al., 2017 demonstrated that affinity of CarD with RNAP is directly proportional to the growth rate in 
Mtb and is independent of 16S rRNA levels, thus indicating that growth rate and rRNA levels can be uncoupled 
in Mtb16.
Mtb CarD and its homologs, alone or in complex with RNAP, have been structurally characterized. Gulten et 
al., solved the structure of monomeric Mtb CarD in complex with RNAP β1-β2 domain of β subunit of RNAP 
and reported that CarDCTD (C-terminal domain of CarD) binds DNA nonspecifically18. Kaur et al., solved the 
crystal structure of Mtb CarD alone and reported that CarD adopts a quasi-domain swapped dimeric architecture 
(Fig. 1a)19. The crystal structure of Thermus thermophilus (Tth) CarD (Fig. 1b)20 and NMR solution structure of 
Myxococcus xanthus (Mxa) CdnL21, homologs of Mtb CarD were also reported recently (Fig. 1c). Recently, Bae et 
al., reported the crystal structure of Tth transcription initiation complex with CarD and demonstrated the role of 
CarD in preventing bubble collapse and in stabilizing the transcription initiation complex22.
The available structural studies suggest that CarD can exist in two distinct oligomeric states, hence the current 
study was primarily aimed at resolving the oligomeric state of CarD in solution. Synchrotron-based small-angle 
X-ray scattering (SAXS) experiments suggest that CarD adopts homodimeric architecture in solution at higher 
μM range concentrations. We also show that CarD has a propensity to form SDS-resistant higher order oligomers 
in solution. Surprisingly, we discovered that CarD has the tendency to form amyloids both in vitro as well as in 
vivo. This makes CarD the second bacterial cytosolic transcription factor, after Clostridium botulinum Rho, a 
transcription termination factor23, and the first Mtb cytosolic protein that has been observed to form amyloid-like 
fibrils.
Figure 1. The comparative structural analysis of four full-length structures of CarD_CdnL_TRCF family 
of proteins. CarD consists of two domains, NTD (marine) and CTD (orange), linked with a flexible linker 
(magenta). The NTDs of the available structures of the CarD_CdnL_TRCF family of proteins (a) Mtb CarD 
(light pink; PDB ID 4KBM) (b) Tth CarD (light green; PDB ID 4L5G) (c) Mxa CdnL (olive; PDB ID 2LWJ) were 
superposed upon domain-swapped dimeric Mtb CarD (PDB ID 4ILU). (d) The crystal structure of Tth CarD 
and the NMR structure of Mxa CdnL were superposed using monomeric Mtb CarD (magenta; PDB ID 4KBM) 
as a reference. Structural comparison reveals different conformational states of CarD observed in available 
structures (indicated by arrows), thus, suggesting flexible nature of the CarD_CdnL_TRCF family of proteins.
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Results
Comparative analysis of the available structures of Mtb CarD and its homologs. Four full-length 
structures belonging to CarD_CdnL_TRCF family of transcription factors have been deposited in the Protein 
Data Bank (PDBIDs 4ILU, 4KBM, 4L5G and 2LWJ). Kaur et al., 2014 reported the crystal structure of domain-
swapped homodimeric Mtb CarD (Fig. 1a), while, Gulten and Sacchettini reported that monomeric CarD binds 
RNAP β in 1:1 stoichiometry (Fig. 1a)18,19. Tth CarD has been crystallized as a monomer (Fig. 1b)20 and in-solu-
tion data for the oligomeric state is unavailable. In case of Mxa CdnL, NMR and analytical ultracentrifugation 
studies have indicated that monomers and dimers co-exist in solution (Fig. 1c)21. Furthermore, bacterial two 
hybrid and size-exclusion studies have suggested that N-terminal region of CdnL interacts with itself and forms 
homodimers in solution21,24. The solution structure of Mxa CdnL reveals high flexibility in the first six N-terminal 
residues21. Superposing the N-terminal domains of the Mtb CarD and its homologs, reveals differences in the 
conformational states of CarD, thus, highlighting the flexible nature of linker in the protein (Fig. 1d). Srivastava 
et al. reported that Tth CarD is rigidly maintained20 whereas our comparative analysis of all the full-length struc-
tures of CarD_CdnL family of proteins suggest that CarD may adopt functionally relevant multiple conforma-
tional states in solution.
CarD exists as a homodimer in solution. To further resolve the oligomeric state of CarD in solution, 
we performed synchrotron based size exclusion chromatography coupled with small angle X-ray scattering 
(SEC-SAXS) experiments. Since the crystal structure of the C-terminal his-tagged CarD (CarDHis) was reported 
previously19, we used CarDHis for performing SEC-SAXS experiments and for performing all the other assays, we 
used both native and CarDHis. CarD eluted as a single peak in the gel filtration chromatography having consist-
ent values of radius of gyration (Rg) across the peak (Fig. 2a inset, Supplementary Fig. 1a). The SAXS scattering 
intensity profile [I(Q)] as a function of Q, Guinier plot, Kratky Plot and normalized pair-distribution function 
[P(r)], are all shown in the Fig. 2(a–d). Analysis of the Guinier plots over a low q (between 0.004 and 0.18 Å−1), 
Figure 2. The SEC-SAXS analysis of CarD. (a) Scattering data obtained for CarD at 277 μM concentration. 
Inset shows the in-line SEC-trace of the CarD. CarD elutes as a single peak with no apparent signs of 
aggregation. FoXS web server analysis reveals that the theoretically calculated scattering profile from domain-
swapped dimeric crystal structure (blue) matches well (χ = 1.23) with the experimentally observed scattering 
profile (black) whereas the monomeric CarD (red) shows relatively poor fit (χ = 1.48). (b) The linear low-q 
region (0.04–0.18) of the scattering curves were used for the Guinier analysis. (c) Kratky analysis of the CarD 
suggests CarD is well folded and flexible in solution. (d) Normalized pair distance distribution [P(r)] function 
suggests Dmax of around 72 Å for CarD.
www.nature.com/scientificreports/
4Scientific REPORTS |  (2018) 8:10124  | DOI:10.1038/s41598-018-28290-4
reveals that the purified protein was free of aggregation and inter-particle interference effects (Fig. 2b). Analysis 
of the Kratky plot and Porod-Debye plots25 suggests that CarD is well-folded globular protein (Fig. 2c). The Porod 
volume estimated from the SEC-SAXS data is 66,457 Å3. The estimated molecular weight (41 kDa) is in close 
agreement with the expected molecular weight of homodimeric CarD (38 kDa). The native-PAGE experiments 
were consistent with the SEC-SAXS results, suggesting the presence of dimeric CarD in solution (Supplementary 
Fig. 1b). In addition, we did not observe any monomeric species of CarD at three different concentrations (8, 
30 and 80 μM) tested in the analytical size exclusion experiments (Supplementary Fig. 1c). The Rg obtained 
from Guinier analysis (Rg = 22.9 ± 0.064 Å) matches closely with the real space Rg derived from P(r) analysis 
(Rg = 21.6 ± 0.084 Å). The Rg and Dmax (maximum dimension) calculated for the monomeric CarD (PDB ID 
4KBM, coordinates extracted for CarD alone) were 17.6 ± 0.049 and 60 Å, respectively whereas the Rg and Dmax 
calculated for dimeric CarD (PDB ID 4ILU) were 22.9 and 72 Å, respectively (Fig. 2d). The Rg and Dmax values 
obtained from the SAXS analysis match well with the Rg and Dmax values calculated for the dimeric CarD using 
FoXS server26 and CRYSOL27, respectively.
DAMMIF28 was used to generate 20 ab initio models which were superimposed, averaged and filtered by 
DAMAVER29 to generate the final model for envelope generation. We then superposed the available crystal struc-
tures of Mtb CarD (PDB ID 4ILU and 4KBM) into the SAXS derived envelope using SUPCOMB30 (Fig. 3). The 
domain-swapped dimeric crystal structure (Fig. 3a) superposed well whereas large unoccupied volumes were 
present when the monomeric CarD structure was superposed in the SAXS envelope (Fig. 3b). The NSD (nor-
malized spatial discrepancy) values calculated using SUPCOMB for dimeric and monomeric CarD were 0.96 
and 3.2, respectively, suggesting better fit for the dimeric CarD. Furthermore, the FoXS web server was used to 
compute the theoretical scattering profile from the crystal structures and compare it with the experimentally 
obtained scattering profile. The SAXS data acquired for CarD matches well with the theoretical scattering profile 
computed from the X-ray crystal structure of dimeric CarD (χ = 1.23) as compared to the monomeric CarD 
(χ = 1.48). Hence, our SAXS data further demonstrates the existence of homodimeric CarD in solution. Taken 
together these results show that CarD is monodisperse, homogeneous and exists as a homodimer in solution at 
the concentrations tested in our study.
CarD undergoes reversible thermal folding in solution. Taken together, the crystal structure as well 
as the solution studies, both confirms the presence of domain-swapping and dimerization in CarD. We assume 
Figure 3. CarD exists as a homodimer in solution. SAXS-derived envelope of CarD was superposed using 
the available crystal structures of Mtb CarD using SUPCOMB. The crystal structure of the domain-swapped 
dimeric CarD fits well into the SAXS calculated envelope (NSD = 0.96, Fig. 3a) whereas the superposition of the 
monomeric CarD (NSD = 3.2, Fig. 3b) leaves multiple regions in the SAXS envelope unaccounted, suggesting a 
poor fit.
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that such a domain-swapped dimer could form by partial unfolding of two monomers, followed by refolding and 
assembly into an intertwined form31,32. To test this hypothesis, we performed thermal denaturation experiments. 
Consistently, circular dichroism (CD) spectra revealed that CarD undergoes reversible thermal melting/folding 
with the presence of isosbestic point at 204 nm (Fig. 4a). The deconvolution of the CD spectra obtained as a 
function of temperature using the BeStSel program33, revealed a ~4-fold decrease in the α-helical content (both 
regular and distorted) when temperature was increased from 20 to 95 °C (Fig. 4b). On the other hand, there was a 
~ 2.5-fold increase in the parallel and anti-parallel β-sheet content (primarily, right-handed twist angle increased 
by ~3-fold (Supplementary Fig. 2) with the increase in temperature. Interestingly, with the decrease in temper-
ature (95 °C to 20 °C), the changes in the secondary structural contents showed the reverse trend (Fig. 4b). The 
presence of highly flexible six N-terminal residues as evident in the solution structure of Mxa CdnL21 and the 
ability to undergo reversible thermal denaturation strongly suggest that CarD may undergo domain-swapping by 
partial unfolding followed by re-assembly with its counterpart.
CarD has a propensity to form higher order oligomers in solution. Domain-swapping in proteins 
has been implicated in the formation for higher order oligomers and even closed spherical shells34–37. We aimed to 
investigate whether domain-swapped CarD oligomers can further self-associate to form higher order oligomers 
in solution. We used mass spectrometry to determine the mass of native CarD. The MALDI-TOF linear mass 
spectrum of the intact CarD shows peaks corresponding to monomeric, dimeric, and trimeric species of CarD 
(Fig. 5a). In order to re-confirm our results, we also performed cross-linking experiments using BS3 [bis(sulfos-
uccinimidyl)suberate chemical cross linker. BS3 contains an amine-reactive N-hydroxysulfosuccinimide (NHS) 
ester at each end of an 8-carbon spacer arm. We incubated CarD with 30-fold and 50-fold molar excess of BS3 
for 1 h at 4 °C and later quenched the reactions by addition of 50 mM Tris-HCl pH 8.0. Bands corresponding to 
the dimeric and higher oligomeric state species were observed on the SDS-PAGE (Fig. 5b). Taken together, these 
data suggest that CarD has a propensity not just to dimerize but also to form higher order oligomeric species in 
solution.
CarD forms SDS-resistant higher order oligomers upon thermal denaturation. There is a 
strong correlation between the ability of a protein to form domain-swapped dimers and amyloids38,39. In several 
instances, domain-swapped oligomers serve as precursors for the formation of the amyloid fibrils, including a 
prion protein40,41, cystatinC42 and GB143. To further investigate whether higher order oligomeric species of CarD 
form amyloid-like fibrils, we performed thermal denaturation experiments. With the increase in temperature, 
dimeric CarD further self-associates to form higher order oligomers as suggested by the native-PAGE analysis 
(Fig. 5c). CarD (50 μM) was incubated at 50 °C for 10 min and samples were analyzed on SDS-PAGE. Though the 
predominant population was monomeric, SDS-resistant dimers and higher order oligomers were formed at low 
efficiency as observed on the SDS-PAGE, a characteristic feature of the amyloids or pili proteins44 (Fig. 5d).
The formation of SDS-resistant higher-order oligomers led us to hypothesize that CarD may also form 
amyloids. We performed bioinformatics analysis using PASTA 2.0 web server to predict “Presence of Amyloid 
STructural Aggregation” in CarD45. The number of amyloid fibril regions predicted by PASTA is 2 and the best 
aggregation pairing energy is −5.406. According to Trovato et al.,46 PASTA based best aggregation pairing energy 
of < −4.0, indicates the presence of cross-β fibrillar aggregates in the structure. The aggregation pairing matrix 
predicts that Met1-Tyr11 N-terminal region of CarD is involved in the self-aggregation and pairing. Amyloid 
fibril regions are no longer detected in PASTA 2.0 server if we delete eleven N-terminal residues of CarD, 
Figure 4. CarD undergoes reversible thermal folding in solution. (a) CD spectra obtained during thermal 
denaturation of CarD (10 μM). CarD was heated from 20 to 95 °C and then cooled from 95 to 20 °C. For clarity, 
only the representative CD spectra acquired at 20 °C, 55 °C and 95 °C during both heating and cooling (labeled 
with ‘_R’) have been plotted. The CD spectra reveal partial unfolding at elevated temperatures and refolding 
upon cooling with the presence of isobestic/isodichroic point at 205 nm. (b) The plot showing variations in 
secondary structural content of CarD with change in temperature. With the increase in temperature, the 
percentage of α-helices decreases and the percentage of anti-parallel β-sheets increases significantly.
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suggesting that the region involved in domain-swapping may also be crucial for the formation of amyloid fibrils. 
We created a CarDtr construct (CarD15–162) and performed thermal denaturation experiments. Upon thermal 
denaturation, no visible precipitates were observed in CarDtr and no SDS-resistant higher order oligomers were 
detected on the SDS-PAGE, suggesting that N-terminal residues are crucial for the formation of SDS-resistant 
higher order oligomers (Supplementary Fig. 3).
CarD forms amyloid-like fibrils in solution. Our results indicated that N-terminal region of CarD 
encompassing β1 is involved in both domain-swapping19 as well as in the formation of SDS-resistant higher 
order oligomers, so, we hypothesized that it may be crucial for the amyloid-fibril formation as well. So, we further 
investigated the ability of CarD to form amyloid-like fibrils using combination of ThioflavinT (ThT) fluorescence 
assay and transmission electron microscopy experiments.
The presence of amyloid fibrils was detected by ThT dye based assay, a fluorescent probe commonly used to 
monitor the formation of amyloid fibrils in vitro47. Upon binding amyloid fibrils, ThT gives a strong fluorescence 
signal at approximately 482 nm when excited at 440 nm. We incubated varying concentrations of CarD (5, 10 and 
100 μM) with ThT at 37 °C for 15 min and observed a significant increase in fluorescence intensity (Fig. 6a). On 
the other hand, when we incubated CarDtr (100 μM) with ThT, no significant increase in fluorescence intensity 
was observed (Fig. 6a), thus, indicating that the N-terminal region encompassing β1 is essential for amyloid for-
mation. Further, the kinetics of formation of amyloid fibrils by CarD (5 µM) was monitored by ThT fluorescence 
at 37 °C for a period of 24 h (Fig. 6b). The fibrillation pattern resembles a characteristic sigmoidal curve consisting 
of a long lag (nucleation) phase, an elongation phase followed by a stationary phase. While the higher concentra-
tions of CarD (100 μM) reached saturation within about 200 mins of incubation at 37 °C, the lower concentrations 
Figure 5. CarD has the tendency to form higher order oligomers in solution. (a) MALDI-TOF based intact 
mass spectrum analysis of CarD (50 μM) shows the presence of monomeric (17.687 kDa), dimeric (35.521 kDa) 
and trimeric (53.400 kDa) species. (b) Chemical cross-linking experiments performed using BS3 demonstrates 
that CarD (50 μM) has a tendency to form dimers, and higher order oligomers in solution. Lane 1, CarD in 
absence of BS3; lane 2, and 3, CarD in presence of 30-fold and 50-fold molar excess of BS3 respectively. L denotes 
the molecular weight ladder used as a standard. (c) CarD samples (50 μM) were incubated at 4, 20, 30, 40, 50, 
and 60 °C for 30 min and resolved in the native-PAGE (10%). Native-PAGE analysis suggests the formation 
of higher order oligomers with increase in temperature. (d) SDS-PAGE analysis of the thermally induced 
higher order oligomers of Mtb CarD (50 μM). L denotes the molecular weight ladder. UH and H represent the 
unheated and heated protein samples of CarD, indicating the formation of SDS-resistant dimers and higher 
order oligomers in the gel. The un-cropped images of the gels shown in b–d are provided in Supplementary 
Fig. 7a–c.
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of CarD showed a comparatively longer lag phase. To further test amyloidogenic property and to reduce the lag 
phase, we performed the seeding experiments by adding preformed nuclei or seeds (5% or 10%) to the sample. 
As expected, addition of seeds reduced the lag phase significantly (Fig. 6b) as compared to the unseeded CarD.
The formation of CarD amyloid-like fibrils was further confirmed by transmission electron microscopy 
(TEM). Electron micrographs reveal the presence of several branched fibrils (protofibrils), ~40–50 Å in diameter 
when imaged after 10 h of incubation (Fig. 6c). The aggregated amyloid fibrils, known as “spikes” were also visible 
in electron micrographs (Fig. 6d). However, we did not observe any fibrils for CarDtr sample in EM studies under 
identical conditions.
CarD forms amyloid inclusions in vivo. ThioflavinS (ThS), being cell permeable, is generally used 
to detect the presence of intracellular amyloid-like structures in live bacterial cells48,49. CarD is essential in 
Mycobacteria but absent in E. coli, hence, we used E. coli as an expression host for investigating in vivo amyloi-
dogenic property of CarD. The bacterial (E. coli) cells carrying empty expression vector, over-expressing CarD 
or CarDtr were stained with ThS and monitored using confocal microscopy. E. coli cells expressing CarD exhibit 
strong green fluorescence along with the presence of several strong foci in majority of the cells thus, suggesting 
that CarD adopts amyloid-like conformations within the bacterial cells (Fig. 7b). In contrast, the E. coli cells car-
rying empty vector exhibit only residual background fluorescence (Fig. 7a). Furthermore, we could observe sig-
nificant cell elongation in the bacterial cells expressing CarD. This observation correlates well with earlier studies 
which demonstrate that aggregation of the amyloidogenic proteins inside bacteria promotes severe cell division 
defects50. However, we did not observe cell elongation in cells over-expressing CarDtr compared to control cells. 
The in vivo confocal imaging of the E. coli cells over expressing CarDtr, stained with ThS, did not show strong 
fluorescent foci suggesting that CarDtr has a reduced ability to form intracellular amyloid inclusions (Fig. 7c).
Figure 6. CarD forms amyloid-like fibrils in solution. (a) Thioflavin T fluorescence assay: Staining of native 
CarD (5, 10 and 100 μM) and CarDtr (100 µM) with amyloid specific fluorescent dye, Thioflavin T (ThT) at 37 °C 
after 15 min shows enhanced fluorescence intensity in case of native CarD as compared to CarDtr. The average 
fluorescence intensity and standard error bars have been calculated from three independent experiments. (b) 
The kinetics of amyloid-like fibril formation of native CarD (5 μM) in the absence and presence of 5% and 
10% seeds monitored at 37 °C. The ThT fluorescence intensity was measured using excitation wavelength of 
440 nm and emission wavelength of 482 nm. (c and d) The transmission electron microscopy (TEM) was used 
to visualize the CarD amyloids. The electron micrographs reveal several branched amyloid-like fibrils (c) and 
spikes (the aggregates of amyloid-like fibrils; d).
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Discussion
In the current study, we attempted to resolve the oligomeric state of CarD in solution and therefore, deter-
mined its solution structure. Consistent with our previous findings19, we report that CarD exists predomi-
nantly as a dimer in solution at μM range of concentrations and has a tendency to form higher order oligomers. 
Concentration-dependent homodimerization has been previously reported in Mxa CarD51. However, Mtb CarD 
is the only example where the domain-swapped dimeric structure has been reported for the CarD_CdnL_TRCF 
family of transcriptional regulators19. The mechanisms or the factors which drive domain-swapping in CarD are 
currently unknown. One of the proposed mechanisms involved in domain-swapping is the ability of the proteins 
to partially unfold and re-fold in an inter-twined form along with their counter-part32. Our CD spectroscopy data 
suggests possible role of partial unfolding/refolding in mediating domain-swapping in CarD. We also report and 
demonstrate an interesting yet peculiar, amyloidogenic property of Mtb CarD, both in vivo as well as physiologi-
cally relevant conditions  in in vitro (5 μM). We observed that deleting the N-terminal fourteen residues involved 
in domain-swapping in CarD results in loss of self-association to form SDS-resistant higher order oligomers and 
hampers its ability to form amyloids in solution. Though in our solution studies we did not observe monomeric 
form of CarD under tested concentrations, Asmat et al.,52 have reported a small population of monomeric CarD 
in gel filtration experiments. The crystal structure of 1:1 stoichiometric complex of Mtb RNAP β1β2/CarD com-
plex suggests that CarD exists as monomer as well in solution18. The protein sample in this study was prepared 
using co-expression and co-purification strategy suggesting probably in the presence of the binding partner, 
CarD exist as a monomer. CarD and RNAP population is similar in cells under normal growth conditions11. 
However, the levels of CarD transcripts increase from 5- to 20-fold under varying stress conditions10. So, under 
stress conditions CarD levels may probably reach in higher μM concentrations (>5 μM) which is in excess of its 
binding partner RNAP and hence, may self-associate to form homodimer. Further, self-association leads to the 
Figure 7.  CarD forms amyloid inclusions in vivo. The confocal fluorescence microscopic images of bacterial 
cells over-expressing (a) empty vector, (b) CarD, and (c) CarDtr. The left, middle and right panels correspond to 
the phase contrast microscopy, fluorescence microscopy and merged images captured under UV light. Scale bar 
corresponds to 10 μm.
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formation of higher order oligomers and amyloid-like fibrils in solution. Currently, it is not clear how and under 
what conditions, and if at all, monomer to dimer transition occurs in CarD. Based on our data, we propose a 
possible model for the formation of CarD amyloids where two N-terminal domains, having unpaired β strands 
probably self-associate by β-augmentation to form amyloid fibrils (Fig. 8). Interestingly, in the crystal struc-
ture of domain-swapped homodimeric Mtb CarD, this unpaired β3 was observed to interact with the flexible 
C-terminal His-tag and the latter also adopted a β strand conformation19. However, CarDHis and tagless CarD 
share similar functional properties suggesting there is no significant effect of histidine tag on the CarD function 
(Supplementary Fig. 4–6).
Usually amyloids are associated with the human diseases53 but there are several instances of functional bacte-
rial amyloids formed by extracellular proteins such as Curli proteins from E. coli54, Type IV Pili from Mtb44, TasA 
from Bacillus subtilis55 and Microcin E492 from Klebsiella pneumoniae56. The presence of amyloidogenic proper-
ties in bacterial cytosolic proteins especially soluble transcription factors has been discovered recently23,57,58. Cbo 
transcriptional terminator Rho23, has been shown to form amyloids intracellularly in yeast and E. coli models. 
So, this field is still at its infancy and offers a wide opportunity to explore physiological relevance of amyloi-
dogenesis in bacterial cytosolic proteins. Interestingly, while our manuscript was under communication, Takacs 
et al., analyzed the structures of all non-amyloid proteins present in PDB and predicted >500 soluble proteins 
with amyloid-like substructures, one of them being Tth CarD (PDBID: 4L5G) (https://arxiv.org/abs/1805.09758). 
Based on our results, we report that CarD is the first soluble cytosolic protein in Mtb which displays the tendency 
to form amyloid-like fibrils. As Mtb has a tendency to stay in a dormant/latent state for decades, hence there is a 
possibility of the formation of intracellular CarD amyloids over such a long period of incubation. So, it would be 
interesting to explore the physiological role, if any, of the amyloid-like fibrils formed by Mtb CarD. Future struc-
tural and functional studies are required to gain mechanistic insights into the phenomenon of domain-swapping 
mediated oligomerization and amyloidogenesis in CarD and similar behaving proteins.
Materials and Methods
Cloning, over-expression, and protein purification. The tagless construct of CarD was PCR amplified 
from Mtb genomic DNA and cloned into pYUB28b vector between NcoI and HindIII sites. The sequence of 
the clones was further confirmed by DNA sequencing. The positive clone of tagless CarD was transformed and 
expressed in E. coli strain BL21(DE3). The CarD overexpressing cells were grown in 1 L Luria Bertani (LB) media 
supplemented with Hygromycin (150 μg/mL) at 37 °C. When the cells reached OD600 = 0.5, the expression was 
induced by adding 0.3 mM IPTG and cells were further incubated for 16 h at 16 °C. The cells were harvested by 
centrifugation at 4 °C and the cell pellet was resuspended in 20 mM MES pH 6.0 and subjected to sonication. 
This was followed by centrifugation at 16,000 × g for 30 min at 4 °C. The supernatant was loaded immediately 
on DEAE-ion exchange chromatographic column pre-equilibrated with 20 mM MES pH 6.0. CarD eluted in the 
same buffer (20 mM MES pH 6.0) with the linear gradient from 0 to 1 M NaCl. The fractions corresponding to 
each peak were loaded on SDS-PAGE and the purified CarD fractions were pooled, concentrated and dialyzed 
in 20 mM HEPES pH 7.5 and 150 mM NaCl for further studies. The N-terminal deletion construct of CarD 
(CarD15–162, referred as CarDtr), was cloned in pNIC28-Bsa4 vector between NdeI and NotI sites. The His-tagged 
constructs of CarD (CarDHis and CarDtr) were purified as per the protocol in Kaur et al.19, except in this study, 
we used 20 mM HEPES pH 7.5 and 150 mM NaCl in all the purification steps. The identity of the protein samples 
Figure 8. Schematic representation showing one of the probable mechanisms for amyloidogenesis in CarD. We 
assume that the N-terminal domains of CarD probably self-associate by β-sheet augmentation (shown in black 
box with broken line) leading to the formation of amyloid-like fibrils. The flexible linker may allow C-terminal 
domain to adopt conformation suitable for the formation of amyloids. The repeating homodimers of CarD are 
shown in blue and orange colors and the region responsible for domain-swapping is shown in magenta box with 
broken lines. For clarity, N-terminal domain has been shown as a topological diagram and C-terminal domain 
has been shown in cartoon representation.
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were confirmed by MALDI-TOF mass spectrometry. The purity of all the protein samples were >95% as judged 
by the SDS- PAGE analysis. All the protein samples were further purified using gel filtration chromatography. The 
purified protein samples (500 μL each) were injected in Superdex S200 10/300 GL column pre-equilibrated with 
20 mM HEPES pH 7.5 and 150 mM NaCl using AKTA purifier FPLC system (GE Healthcare) with a flow rate of 
0.5 mL/min.
Size-exclusion chromatography coupled with small angle X-ray scattering (SEC-SAXS). 
SEC-SAXS was performed at the Diamond Light Source, Harwell, UK at B21 beamline. Inline SEC-SAXS data 
was collected using an Agilent HPLC equipped with Shodex column. Data were recorded on a Pilatus 2 M detec-
tor and purified samples of CarD (277 μM) were loaded onto the Shodex column pre-equilibrated in the running 
buffer of 20 mM HEPES pH 7.5 and 150 mM NaCl, at a flow rate of 0.018 mL/min at 4 °C. The primary reduction 
of the SAXS data and data processing were performed using ScÅtter (http://www.bioisis.net/ScÅtter) to obtain 
the radius of gyration (Rg), the maximum particle dimension (Dmax), the excluded particle volume (Vp) and the 
pair distribution function [P(r)]. The molecular mass of the scattering particles was calculated using a method 
described by Rambo et al.59. Low resolution 3-D ab initio models were generated using DAMMIF software28 
using the slow mode. Averaging the results of 20 independent runs using DAMAVER29 generated the dummy 
atom models which were superposed with the monomeric and domain-swapped dimeric crystal structures of 
Mtb CarD using SUPCOMB30. Structural visualization, analysis and figure preparation were performed using 
PyMoL (Schrödinger, LLC). FoXS web server26 was used to fit the experimentally derived scattering profile to the 
theoretically calculated scattering profile from the crystal structure. FoXS web server26 and CRYSOL27 were used 
for calculating Rg and Dmax from the crystal structure and the experimental obtained SAXS data.
CD spectroscopy and thermal melt assays. CarD or CarDHis (10 μM each) were dialyzed overnight 
into 10 mM sodium phosphate buffer (pH 7.5). CarD or CarDHis in a 1 mm path-length quartz cuvette were used 
to collect CD spectra in the 195–250 nm and 190–250 nm wavelength range, respectively, using JASCO J-810 
spectrometer. Thermal melt experiments were performed from 20 to 95 °C and 95 to 20 °C temperature ranges 
with ramp rate of 1 °C/min. The spectra were recorded at every 5 °C with a scanning speed of 100 nm/min. The 
secondary structural content was deconvoluted using BeStSel Server33.
Intact Mass Spectrometry analysis. Purified CarD (50 μM) or CarDHis or CarDtr were mixed with sinap-
inic acid matrix solution (50% Acetonitrile/50% water with 0.1% Trifluoroacetic acid) in 1:1 ratio and the mix 
was spotted on the MALDI plate. The spots were air dried and data were acquired in linear and positive ion mode 
keeping the laser intensity between 3000–3400 V (AB Sciex TOF/TOF 5800). The data were analyzed using Data 
Explorer software version 4.9 of Applied Biosystems.
Chemical cross-linking. Cross-linking by BS3 [bis(sulfosuccinimidyl)suberate, Thermo Scientific, Catalog 
number 21580] was performed according to the method described in the user guide. CarD or CarDHis (50 μM 
each in 20 mM HEPES pH 7.5 and 150 mM NaCl) were mixed with 30-fold (1.2 mM) and 50-fold molar (1.5 mM) 
excess of BS3 and incubated on ice for 1 h. To terminate the cross-linking reaction, 50 mM Tris-HCl (stock solu-
tions 1.5 M, pH 8.0) were added to the reaction mixtures after 1 h. The cross-linked proteins and the control 
protein samples were mixed with 2× SDS loading dye and resolved on the 15% SDS-PAGE.
Native-PAGE analysis. Samples of purified CarD (50 μM) and CarDHis (50 to 716 μM) were incubated from 
4 to 60 °C for 30 min. The heated samples were mixed with 2× non-denaturing gel loading dye (200 mM Tris-HCl, 
pH 6.8, 0.2% bromophenol blue and 20% glycerol). The continuous native-PAGE (10%) was cast and pre-run at 
10 V/cm for 30 min at 4 °C. Electrophoresis was performed in 1× native-PAGE running buffer (25 mM Tris-HCl, 
pH 8.3, 192 mM glycine) according to the standard method at 4 °C for 2 h. The gels were stained using Coomassie 
brilliant blue followed by destaining using standard protocol.
Thermal denaturation. To perform thermal denaturation experiments, CarD (50 μM), CarDHis (100 µM) 
or CarDtr (100 µM) were incubated at 50 °C for 10 min. The samples were then immediately mixed with 2× SDS 
loading dye and resolved on the 15% SDS-PAGE. The protein bands were visualized using standard staining and 
destaining protocols.
Thioflavin T (ThT) fluorescence and fibrillation assays. Native tagless CarD (5, 10 and 100 μM), 
CarDHis (100 μM) and CarDtr (100 μM) were mixed with 10-fold molar excess of ThT and incubated for 15 min 
at 37 °C. Seeding experiments were performed where 5% and 10% seeds were transferred from the 100 μM CarD 
sample incubated at 37 °C for 5 h to 5 μM CarD. The ThT fluorescence intensity was measured using excitation 
wavelength of 440 nm and emission wavelength of 482 nm. The fluorescence measurements were recorded using 
Synergy H1 Hybrid multi-mode microplate reader. The kinetics for the formation of amyloid fibrils by CarD and 
CarDHis were recorded for a period of 24 h. The microplate reader was set at constant temperature of 37 °C and 
readings were acquired every 2 min with continuous orbital shaking between reads over a period of 24 h. The top 
of the each well was sealed using adhesive tape to minimize the rate of evaporation.
Transmission Electron Microscopy (TEM). Aliquots of 20 μL from samples containing CarD or CarDtr 
stained with ThT fluorescent dye were pipetted on a carbon-coated 300-mesh copper grid (Polysciences). Samples 
were diluted five-fold using 20 mM HEPES pH 7.5 and 150 mM NaCl buffer before loading on the grids. The 
excess sample was blotted and the grids were incubated with uranyl acetate solution (2%) for 2 min at room 
temperature followed by air drying. The grids were imaged using a JEM 2100 transmission electron microscope, 
operated at 200 keV (JEOL).
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Thioflavin S (ThS) staining of live bacterial cells. E. coli BL21(DE3) cells harboring CarD or CarDtr 
expression vector and empty expression vector control were grown at 37 °C in LB medium until optical density 
(OD600) reached 0.5. The protein expression was induced by addition of 0.3 mM IPTG and the cultures were 
further grown at 37 °C for 5 h after induction. Thereafter, 0.5 mL of each bacterial culture was centrifuged at 
6000 × g, 25 °C for 2 min. The bacterial cultures were washed thrice with 1 × PBS, followed by their fixation using 
4% paraformaldehyde at 37 °C for 30 min. The fixed bacterial cultures were washed thrice with 1 × PBS and fur-
ther incubated with 125 μM ThioflavinS (ThS, Catalog number T1892, Sigma) at 37 °C for 30 min in the dark. The 
bacterial cultures were again resuspended and washed thrice with 1 × PBS. 10 μL of the sample was placed on top 
of the glass slide, covered with a coverslip and air-dried. The images were acquired using confocal fluorescence 
microscope (Nikon A1R), using a 100 × oil-immersion objective and 1 Airy unit aperture. The ThS stained sam-
ples were excited using an excitation wavelength of 405 nm and an emission wavelength of 482 nm.
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